Establishment Labs Holdings Inc. (ESTA)
$72.06-0.84%Close
SELLCRISIS · day 3
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $2.1B
- Avg volume
- 587.6K
- Beta
- 1.09
- P/E (TTM)
- -55.08
- Short % float
- 16.15%
- Days to cover
- 9.9
- SI change
- -3.1%
- 1W
- -5.95%
- 1M
- -21.95%
- 3M
- -0.18%
- YTD
- +4.68%
- vs SPY 1W
- -4.76%
- vs SPY 1M
- -25.27%
- vs SPY 3M
- -2.57%
- vs SPY YTD
- -7.08%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- CGONBUYCG Oncology, Inc. Common stockBULLQ 32$78.23-1.98%
- DNLIBUYDenali Therapeutics Inc.RECOVERYQ 10$24.20-2.89%
- FHTXBUYFoghorn Therapeutics Inc.RECOVERYQ 4$6.87-2.83%
- CNTBBUYConnect Biopharma Holdings LimitedRECOVERYQ -12$2.30-2.54%
- KYMRBUYKymera Therapeutics, Inc.BULLQ 27$121.05+1.04%
- ROIVBUYRoivant Sciences Ltd.BULLQ 31$36.36+0.17%
- COYABUYCoya Therapeutics, Inc.RECOVERYQ 9$4.96+1.85%
- ABCLBUYAbCellera Biologics Inc.RECOVERYQ -7$10.61-6.27%
- RCUSBUYArcus Biosciences, Inc.RECOVERYQ 19$30.12-0.73%
- LYRASELLLyra Therapeutics, Inc.CRISISQ -25$0.01
- CTSOSELLCytosorbents CorporationCRISISQ 2$0.37+0.00%
- CTXRBUYCitius Pharmaceuticals, Inc.CRISISQ -11$0.58-3.33%
Industry peers
FMP comparable companies · ranked by market cap
- SYREBUYSpyre Therapeutics, Inc.$9.5BBULLQ 11$108.92+0.15%
- UFPTBUYUFP Technologies, Inc.$2.4BBULLQ 23$312.84-1.21%
- NVCRBUYNovocure Ltd$2.1BRECOVERYQ 12$18.20-1.99%
- ZYMEBUYZymeworks Inc.$2.0BRECOVERYQ 13$27.21+0.35%
- AZTABUYAzenta, Inc.$1.6BRECOVERYQ 9$35.62-12.09%
- KMTSBUYKestra Medical Technologies, Ltd.$1.6BBULLQ 23$27.91-0.30%
- CNMDBUYCONMED Corporation$1.5BRECOVERYQ 13$51.25+0.82%
- TDOCSELLTeladoc Health, Inc.$1.2BCRISISQ 1$6.66-2.97%
- AHCOSELLAdaptHealth Corp.$770MCRISISQ -1$5.66+0.00%
- SSIISELLSS Innovations International, Inc.$720MRECOVERYQ 17$3.60-2.51%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 4
- VALUE
- 0
- GROWTH
- 20
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-122.3%
REV YoY-
ROE-203.9%
EPS YoY-
ROA-11.1%
GROSS70
OP-8
NET-16
[VALUATION]
P/E TTM-55.08
P/E FWD-
SECTOR PE22.66
INDUSTRY PE24.61
P/B100.46
P/FCF-
EV/EBITDA-345.57
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E1220.32
ALTMAN Z-
CURR RATIO3.84
ND/EBITDA-
BETA1.09
